kabutan

M3, Inc.(2413) Summary

2413
TSE Prime
M3, Inc.
1,520.0
JPY
+5.0
(+0.33%)
Apr 28, 3:30 pm JST
9.54
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
1,512
Apr 28, 11:53 pm JST
Summary Chart Historical News Financial Result
PER
22.5
PBR
2.43
Yield
ー%
Margin Trading Ratio
13.36
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
1,531.5 JPY 9.61 USD
Previous Close Apr 27
1,515.0 JPY 9.50 USD
High Apr 28, 9:47 am
1,540.0 JPY 9.66 USD
Low Apr 28, 9:02 am
1,510.5 JPY 9.47 USD
Volume
2,772,400
Trading Value
4.22B JPY 0.03B USD
VWAP
1522.3 JPY 9.56 USD
Minimum Trading Value
152,000 JPY 954 USD
Market Cap
1.03T JPY 6.49B USD
Number of Trades
5,520
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
High
1-Year Average
7,913
1-Year High Aug 7, 2025
48,319
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 261,400 5,385,000 20.60
Apr 17, 2026 217,000 4,731,800 21.81
Apr 10, 2026 227,300 4,544,800 19.99
Apr 3, 2026 234,900 4,457,600 18.98
Mar 27, 2026 1,869,700 4,633,000 2.48
Company Profile
M3, Inc. is a Sony Group affiliate specializing in pharmaceutical marketing support. It provides information through a website for physicians and is also involved in telemedicine.
Sector
Services
M3, Inc., a member of the Sony Group, aims to revolutionize the medical world through the use of the internet. The company operates various services both domestically and internationally, centered around its professional medical website "m3.com". Its main business activities include marketing support for medical-related companies, surveys targeting healthcare professionals, practice management services, clinical trial support, CSO operations, and the development and sale of electronic medical records. M3 also engages in evidence solution services such as clinical development support, clinical trial management and operational support, and subject recruitment assistance. Additionally, the company provides human resource services for medical professionals, management support for medical institutions, and operates hospice facilities. Internationally, M3 has expanded its operations globally, offering marketing support, surveys, human resource services for medical professionals, and clinical trial support.